Ketoconazole Prices: Chart, Market Analysis, Price Trends and Forecast 2026

According to ChemAnalyst, The global Ketoconazole prices experienced mixed regional movements during the second quarter of 2026, as rising production costs, changing manufacturing economics, and differences in regional demand influenced pricing trends. In North America, ketoconazole prices moved upward quarter-over-quarter, supported by increased production expenses and higher industrial input costs. In the Asia-Pacific (APAC) region, prices also increased, reflecting cost pressures affecting pharmaceutical manufacturing, particularly toward the end of the quarter. Meanwhile, the European market remained relatively stable, supported by balanced demand conditions despite higher producer prices.

Ketoconazole is an imidazole-class antifungal active pharmaceutical ingredient (API) used in the production of medicines designed to treat fungal infections. It has applications in topical formulations, including creams, shampoos, and other dermatological preparations. Demand for ketoconazole is closely connected to pharmaceutical manufacturing activity, dermatology treatment requirements, procurement strategies, and the availability of compliant API supplies.

During Q2 2026, the United States experienced higher production costs, with the Producer Price Index (PPI) increasing by 5.5% year-over-year in June 2026. In China, rising manufacturing expenses contributed to upward price movements, while ketoconazole prices in Germany remained broadly stable despite an increase in industrial producer prices of 2.2% year-over-year in May 2026. In the APAC market, ketoconazole prices were assessed at USD 72,000/MT FOB India, providing an important regional reference for buyers and procurement professionals.

Overall, the ketoconazole market reflected a combination of cost-driven price increases and region-specific demand conditions. These developments highlighted the importance of monitoring production expenses, supplier availability, and international trade conditions when evaluating ketoconazole procurement costs.

Ketoconazole Prices in North America

United States Ketoconazole Price Trends

In the United States, the Ketoconazole Price Index increased quarter-over-quarter during Q2 2026, primarily because of rising production costs and higher input expenses across the industrial and pharmaceutical supply chain. The upward movement reflected the broader cost environment facing manufacturers, including expenses associated with raw materials, utilities, labour, quality control, and regulatory compliance.

A significant indicator of the prevailing cost environment was the 5.5% year-over-year increase in the US Producer Price Index in June 2026. Although this economy-wide producer price movement does not directly measure ketoconazole API prices, it indicates the broader inflationary pressures that can influence manufacturing and procurement costs.

Pharmaceutical API production requires controlled processing conditions, reliable raw-material sourcing, specialised equipment, and stringent quality assurance procedures. Manufacturers must also maintain appropriate documentation and comply with applicable quality standards. When operating expenses rise, suppliers may attempt to recover some of the additional costs through higher selling prices, particularly when production capacity or alternative supply options are limited.

During the quarter, these cost pressures contributed to the upward movement in US ketoconazole prices. Buyers purchasing imported or domestically sourced material had to consider not only the quoted API price but also freight, insurance, customs-related expenses, warehousing, and supplier qualification costs.

Get Real Time Online for Ketoconazole Prices: https://www.chemanalyst.com/Pricing-data/ketoconazole-1508

Factors Supporting the Increase in North American Prices

Production costs remained a major factor influencing the North American ketoconazole market. Energy expenses, labour costs, equipment maintenance, and quality assurance requirements can all affect the total cost of manufacturing pharmaceutical ingredients. Changes in the prices of chemical intermediates and other production inputs may also influence supplier offers.

Procurement strategies further shaped market conditions. Pharmaceutical manufacturers typically assess API suppliers based on price, product quality, regulatory documentation, consistency of supply, and delivery reliability. Switching suppliers can require technical assessments and qualification procedures, which may limit the speed at which buyers respond to price increases.

Demand from manufacturers of topical antifungal medicines also remains relevant to the market. However, ketoconazole demand depends on formulation type, product applications, prescribing patterns, inventory levels, and competition from alternative antifungal ingredients. Consequently, higher production costs do not automatically translate into equivalent increases in demand or selling prices.

During Q2 2026, the upward movement in the US Ketoconazole Price Index indicated that cost pressures were an important influence on the market. Buyers therefore had to balance cost control with the need to maintain dependable API supplies.

Ketoconazole Prices in APAC

China Ketoconazole Price Trends

In China, the Ketoconazole Price Index increased quarter-over-quarter during Q2 2026, supported by rising production costs, particularly toward June. China remains an important participant in the pharmaceutical chemicals and API supply chain, and changes in its manufacturing economics can influence supplier quotations and international procurement decisions.

The increase in Chinese ketoconazole prices reflected the impact of higher manufacturing expenses on supplier pricing. Pharmaceutical ingredient production involves multiple cost components, including chemical intermediates, energy, labour, processing, purification, testing, packaging, and quality management. Increases in these expenses can place pressure on manufacturers’ margins and encourage price adjustments.

The broader Chinese industrial environment also influenced the market backdrop. Producer prices for industrial products increased by 4.1% year-over-year in June 2026, indicating a changing cost environment across the industrial economy. This indicator should be interpreted as broader economic context rather than a direct measure of ketoconazole manufacturing costs.

For ketoconazole suppliers, the extent to which higher expenses translate into selling prices depends on production efficiency, inventory positions, competitive pressure, order volumes, and the availability of alternative suppliers. Manufacturers with adequate inventories or efficient production processes may be better positioned to manage cost increases than those facing higher marginal production expenses.

Chinese suppliers also operate in an export-oriented pharmaceutical ingredients market, where international customers evaluate prices alongside product specifications, documentation, delivery schedules, and supplier reliability. Changes in domestic manufacturing costs can therefore influence export quotations, although currency movements, logistics expenses, and destination-market requirements also play a role.

During Q2 2026, the upward movement in the Chinese Ketoconazole Price Index suggested that suppliers were operating in a more cost-intensive environment. Market participants continued to monitor manufacturing expenses and supplier offers to assess the direction of prices.

India Ketoconazole Prices and Export Market

In India, ketoconazole prices were assessed at USD 72,000/MT FOB India during the quarter. This assessment provides a reference point for buyers evaluating export-oriented ketoconazole procurement from Indian suppliers.

The FOB (Free on Board) basis generally indicates that the seller delivers the goods on board the vessel at the designated port, with the applicable allocation of costs and risks governed by the agreed Incoterms. Under a typical FOB arrangement, the overseas buyer is responsible for the main ocean freight and insurance after the goods are loaded, subject to the contract terms.

India’s pharmaceutical manufacturing sector plays an important role in the international supply of APIs and pharmaceutical intermediates. Buyers often evaluate Indian suppliers for product consistency, technical documentation, manufacturing capabilities, and export reliability. These considerations are especially important for pharmaceutical ingredients that must meet defined quality requirements.

The assessed price of USD 72,000/MT FOB India can support preliminary procurement comparisons, but buyers should confirm the grade, assay, impurity profile, batch size, packaging, payment terms, delivery schedule, and quotation validity before making purchasing decisions. Prices can vary significantly depending on the precise product specification and commercial arrangement.

The Indian ketoconazole market is also influenced by the cost and availability of chemical intermediates, energy, labour, and manufacturing services. Export quotations may additionally reflect currency movements, domestic inventory levels, competition between suppliers, and freight-market conditions.

For international buyers, comparing FOB India quotations with delivered prices from other origins requires adjustments for freight, insurance, import duties, customs clearance, and local handling. A lower quoted export price does not necessarily translate into the lowest landed cost.

Overall, the APAC ketoconazole market experienced upward price pressure during Q2 2026. The combination of rising costs in China and the reported Indian FOB assessment highlighted the importance of regional supplier comparisons and careful evaluation of total procurement expenses.

Ketoconazole Prices in Europe

Germany Ketoconazole Price Trends

In Germany, the Ketoconazole Price Index remained broadly stable during Q2 2026, reflecting balanced demand and cost pressures. Unlike the upward price movements reported in North America and China, the European market showed relative stability as market participants balanced higher production expenses against prevailing purchasing conditions.

Industrial producer prices in Germany increased by 2.2% year-over-year in May 2026. This rise indicated that manufacturers continued to face cost pressures, although the effect on ketoconazole prices depended on the structure of individual supply contracts, sourcing arrangements, and supplier margins.

The pharmaceutical sector operates within a highly quality-sensitive environment. API buyers typically prioritise reliable supply, consistent product specifications, regulatory documentation, and manufacturing quality alongside price. These requirements can limit the number of immediately acceptable suppliers and influence purchasing decisions.

Nevertheless, stable prices can persist even when manufacturing costs rise. Suppliers may absorb some additional expenses to maintain customer relationships, particularly where demand is steady and competitive pressure limits their ability to increase quotations. Existing inventories and previously negotiated supply agreements can also delay the transmission of cost increases to buyers.

In Germany, balanced demand conditions helped offset the influence of higher industrial producer prices. Pharmaceutical manufacturers and distributors continued to evaluate purchasing requirements against available inventories, planned production schedules, and expected customer demand.

European Supply and Procurement Conditions

European ketoconazole procurement is shaped by international API trade, supplier qualification requirements, logistics costs, and compliance expectations. Importers must assess whether suppliers can provide the documentation and quality information required for their intended pharmaceutical applications.

Freight costs and delivery lead times can influence the final procurement cost, even when the underlying API quotation remains unchanged. Currency movements may also affect purchases sourced from overseas manufacturers, depending on the invoicing currency and the buyer’s commercial arrangements.

During Q2 2026, the stable German Ketoconazole Price Index suggested that the market was able to absorb prevailing cost pressures without a substantial change in the reported price trend. However, stability during one quarter does not guarantee that prices will remain unchanged in subsequent periods.

Future movements will depend on changes in raw-material costs, supplier availability, purchasing volumes, inventory management, and international logistics. Buyers should therefore continue monitoring supplier quotations and broader industrial indicators when developing procurement plans.

Key Factors Influencing Global Ketoconazole Prices

Several interconnected factors influenced the global ketoconazole market during Q2 2026.

Raw-Material and Manufacturing Costs

The cost of chemical intermediates, reagents, energy, labour, and production equipment can influence ketoconazole manufacturing expenses. Higher input costs may place pressure on supplier margins and contribute to higher quotations, particularly when manufacturers cannot offset the increases through improved efficiency.

Industrial Producer Price Inflation

Industrial price indicators provide useful context for understanding changes in manufacturing economics. The reported increases in US producer prices and Chinese industrial producer prices highlighted cost pressures during June 2026, while Germany’s May increase indicated a similar, though comparatively moderate, movement.

These indicators do not directly represent ketoconazole prices, but they help explain the broader economic environment in which pharmaceutical ingredient suppliers operate.

Pharmaceutical Demand and Inventory Management

Demand from API buyers depends on production schedules, downstream formulation requirements, inventory coverage, and expected sales of antifungal products. Strong purchasing activity can support prices, whereas excess inventory or delayed orders can limit suppliers’ ability to pass on cost increases.

Supplier Availability and Quality Requirements

Pharmaceutical buyers must consider product quality, consistency, documentation, and supplier qualification. Limited availability of approved or technically suitable suppliers may increase procurement costs, while broader supplier competition can help moderate prices.

International Trade and Logistics

Freight rates, insurance, currency fluctuations, import requirements, and delivery schedules influence the final cost of internationally traded ketoconazole. FOB quotations should therefore be evaluated alongside transportation and destination-related expenses.

Ketoconazole Price Outlook for the Second Half of 2026

Looking ahead to the second half of 2026, the direction of ketoconazole prices will depend on the balance between manufacturing costs, supplier competition, pharmaceutical purchasing activity, and the availability of API inventories.

In North America, continued increases in production expenses could sustain upward price pressure if manufacturers pass higher costs on to customers. However, the extent of any further increase will depend on supplier quotations, purchasing volumes, and the availability of alternative sources.

In APAC, the Chinese market will remain sensitive to manufacturing expenses, production efficiency, and export demand. Indian suppliers’ pricing will also depend on raw-material availability, domestic operating costs, international orders, and commercial terms. The Q2 2026 assessment of USD 72,000/MT FOB India offers a historical reference point, but it should not be treated as a confirmed quotation for later quarters.

In Europe, the comparatively stable price trend observed in Germany may continue if demand and supply remain balanced. Nevertheless, higher manufacturing expenses, changes in import costs, or disruptions to international logistics could alter supplier pricing.

For buyers, the most effective approach is to monitor ketoconazole quotations regularly, compare offers from qualified suppliers, maintain appropriate inventory coverage, and evaluate total landed costs rather than relying solely on headline prices. Longer-term supply agreements and diversified sourcing strategies may also help manage exposure to sudden market changes.

These expectations are conditional market scenarios rather than confirmed price forecasts. Reliable projections require additional information on current supplier offers, transaction volumes, inventory positions, and subsequent-quarter cost developments.

Book A Demo for Ketoconazole Prices: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Ketoconazole

Conclusion

The global Ketoconazole Prices market recorded mixed regional trends during Q2 2026. North America experienced quarter-over-quarter price increases amid rising production costs, while China also reported upward price movements. In India, ketoconazole prices were assessed at USD 72,000/MT FOB India. Germany, meanwhile, maintained a broadly stable price trend despite higher industrial producer prices.

The reported economic indicators highlighted the role of manufacturing expenses in shaping supplier pricing, although regional demand, inventory levels, competition, and logistics also influenced market conditions. As the market progresses through the second half of 2026, pharmaceutical buyers should monitor regional price assessments, qualify reliable suppliers, and evaluate total procurement costs to support informed purchasing decisions.

About Us:

Welcome to ChemAnalyst, a next–generation platform for chemical and petrochemical intelligence where innovation meets practical insight. Recognized as “Product Innovator of the Year 2023” and ranked among the “Top 100 Digital Procurement Solutions Companies,” we lead the digital transformation of the global chemical sector. Our online platform helps companies handle price volatility with structured analysis, real-time pricing, and reliable news and deal updates from across the world. Tracking over 500 chemical prices in more than 40 countries becomes simple and efficient with us.

Contact Us:

Address:

420 Lexington Avenue, Suite 300 New York, NY 10170 United States

Phone: +1 332 258 6602

Email: [email protected]

Website: https://www.chemanalyst.com/

LinkedIn: https://www.linkedin.com/company/chemanalyst/

Facebook: https://www.facebook.com/ChemAnalysts/

Twitter: https://x.com/chemanalysts

YouTube: https://www.youtube.com/@chemanalyst

Instagram: https://www.instagram.com/chemanalyst_